Adekunle (Kunle) Odunsi
AbbVie Foundation Distinguished Service Professor
Department of Obstetrics and Gynecology and Department of Medicine
Adekunle (Kunle) Odunsi is a gynecologic oncologist and an expert in immunotherapy and vaccine therapy for cancer. His research focuses on understanding the mechanisms of immune recognition and tolerance in ovarian cancer and translating these findings to immunotherapy clinical trials. He pioneered the development of antigen-specific vaccine therapy and “next-generation” adoptive T-cell immunotherapies to prolong remission rates in women with ovarian cancer. He will serve as the Biological Sciences Division’s Dean for Oncology.
His honors and awards include election to the National Academy of Medicine and the Rosalind Franklin Prize for Excellence in Ovarian Cancer Research. His work has been funded by the National Institutes of Health, US Department of Defense, Ludwig Institute for Cancer Research, Cancer Research Institute, and Ovarian Cancer Research Alliance. He is co-chair of the National Cancer Institute Immuno-oncology Translational Network and chairperson-elect of the American Association for Cancer Research’s Cancer Immunology Working Group.
Odunsi received his medical degree from the University of Ife in Nigeria and his PhD from the Imperial Cancer Research Fund Laboratories, MRC Weatherall Institute of Molecular Medicine at the University of Oxford. He completed residencies in obstetrics and gynecology at the University of Cambridge and Yale School of Medicine, and a fellowship in gynecologic oncology at Roswell Park Comprehensive Cancer Center in Buffalo, New York.